Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
about
Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignanciesStructural Mechanisms and Drug Discovery Prospects of Rho GTPasesFunctions of TET Proteins in Hematopoietic TransformationIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?The double face of Morgana in tumorigenesisG17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cellsConnections between TET proteins and aberrant DNA modification in cancerClinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyondIDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.The RhoA-ROCK pathway in the regulation of T and B cell responsesRole of TET enzymes in DNA methylation, development, and cancerMyo9b is a key player in SLIT/ROBO-mediated lung tumor suppressionComprehensive molecular characterization of gastric adenocarcinomaGender-Specific Molecular and Clinical Features Underlie Malignant Pleural MesotheliomaRomidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative dataData on affected cancer-related genes in pediatric t(12;21)-positive acute lymphoblastic leukemia patients harboring unbalanced der(6)t(X;6) translocations.Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.Toward a Biology-Driven Treatment Strategy for Peripheral T-cell LymphomaMolecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives.The curious origins of angioimmunoblastic T-cell lymphomaDetection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes.DNMT3A in haematological malignancies.The mutational landscape of cutaneous T cell lymphoma and Sézary syndromeTET proteins and the control of cytosine demethylation in cancer.Gentamicin arrests cancer cell growth: the intriguing involvement of nuclear sphingomyelin metabolismLoss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.TET proteins and 5-methylcytosine oxidation in hematological cancersSTX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomasIdentification of cell-type-specific mutations in nodal T-cell lymphomas.Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell linesDNA methylation and hydroxymethylation in hematologic differentiation and transformation.Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents.Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice.The Impact of DNA Methylation in Hematopoietic Malignancies.CD1d-restricted peripheral T cell lymphoma in mice and humans.A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice
P2860
Q26739689-385CF5D6-ED56-4812-9F36-A55BF75F1424Q26745863-A24DF28F-EBB0-488F-8A9E-76BE97BD2C92Q26778323-EFE17B08-3328-412F-BF93-BA7D7880FD63Q26779702-9F53C03E-D824-49EE-89C9-16469B09DAC7Q26783788-0E0F52F8-A2CB-4232-816C-97FE5A2008ADQ26863411-3577533E-F882-4ECE-BF1B-FF879C4C120AQ26865671-79593EF2-CA60-44F9-834B-04B964480E8EQ27027493-71BFD290-7D64-4777-840B-61E260C7DE98Q27853198-ECCFA5FC-5D99-4601-B927-990F8C359775Q28066137-C1533AE0-7644-43D5-B770-A459D637322FQ28068541-5925EF8B-5532-463C-AD5D-01D625AED1B3Q28117738-7036646E-8D01-46BF-9D3F-711EC26DEF6DQ28244985-5A7D0182-44D5-4CC3-A857-DD71D107D006Q28384371-76F194DA-1F07-41DD-AFF8-D4EA452813CBQ30936712-66A7EAED-5CC5-404E-9403-CA48F92AAAF5Q31120836-35D8A2BF-85CE-41C4-BC1D-502C24AA5AC6Q33566663-7A3ACE08-E067-494F-9085-FC4ED8309303Q33670421-1B420BA7-EAEC-45FF-8CEC-4359DE8302CBQ33729711-EF0282C8-EE1A-428C-9416-AD61EC123D91Q33877993-D17BCA00-A817-4F7B-BFBC-477C00AEEA79Q34332071-2B20F2B7-3A3C-495B-B19C-49C59DDBBA65Q34444243-188B0AD4-5668-4D7F-88B0-D5A80C0CDA24Q34463554-64E81C8C-152A-4FC0-8766-52E5AD039ED4Q34501143-DA8EBCF3-5200-4B22-B315-79804C886D5EQ35021377-8BA39282-65BC-4A13-B395-2800DFED558DQ35138856-046F20BF-C2BF-499C-883E-5AC47C864CADQ35648144-F80F8096-9B3B-4CE2-83B7-C11013D03B40Q35808018-7F3C4A80-C2EA-488E-ADD6-F056E666246DQ35832062-7DD19C25-1A0D-4FFD-A2CB-426612C92554Q36197509-9481B5D4-09D3-4A50-B363-05591D340E95Q36262870-226CA2D8-15D9-4562-A612-0EC714A2E554Q36269008-20975FC2-71B3-4C8A-9F05-DC3E04B6B8DBQ36372043-FEB2E968-BD27-47A2-8793-F02422FC38B7Q36395976-52532AF3-9954-4B1E-9FEE-756BF1B69D34Q36627526-49ADB17F-BE4E-45C6-B67E-5353D99AD402Q36675069-B4A3B267-F1C1-45C8-9670-462A196FEEFEQ36724810-C0F81A79-35C8-4C32-89CF-D48CA695C4AEQ36863110-2991419E-6266-4487-A2F5-BCE9360B11A2Q36893709-91B230C0-F361-45B0-AC73-62DE0408C1B6Q36908743-B6A2079E-877E-4F1F-B0FE-F94D5E1F30FB
P2860
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recurrent mutations in epigene ...... in peripheral T cell lymphomas
@en
Recurrent mutations in epigene ...... n peripheral T cell lymphomas.
@nl
type
label
Recurrent mutations in epigene ...... in peripheral T cell lymphomas
@en
Recurrent mutations in epigene ...... n peripheral T cell lymphomas.
@nl
prefLabel
Recurrent mutations in epigene ...... in peripheral T cell lymphomas
@en
Recurrent mutations in epigene ...... n peripheral T cell lymphomas.
@nl
P2093
P2860
P50
P356
P1433
P1476
Recurrent mutations in epigene ...... in peripheral T cell lymphomas
@en
P2093
Adolfo A Ferrando
Arianne Perez-Garcia
Christian Bastard
Concha Nicolas
Francesco Abate
Izidore S Lossos
J Erika Haydu
Maddalena Allegretta
Mi-Yeon Kim
Milagros Balbin
P2860
P2888
P304
P356
10.1038/NG.2873
P407
P50
P577
2014-01-12T00:00:00Z
P5875
P6179
1040376253